Home › Endometrial Cancer › Wisconsin
Endometrial Cancer clinical trials in Wisconsin
24 studies for Endometrial Cancer are looking for participants at sites in Wisconsin.
Cities in Wisconsin
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT05112601Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT05950464Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- and 42 more
RecruitingPhase 2
All ages · All sexes · Updated Nov 12, 2026 · NCT05564377Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT05640999Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Duluth Clinic Ashland, Ashland
- Saint Vincent Hospital Cancer Center Green Bay, Green Bay
- Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay
- and 8 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT07198074Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Mayo Clinic Health System - Northwest Wisconsin, Eau Claire
- Mayo Clinic Health System - Southwest Wisconsin, La Crosse
RecruitingObservational study
Ages 18 and older · Women · Updated Nov 5, 2026 · NCT05051722A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
- Minnesota Oncology Hematology, P.A., Hudson
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 30, 2026 · NCT07578649A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Froedtert & MCW Cancer Center, Milwaukee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07109726Study of EV for Recurrent Endometrial Carcinoma
- Froedtert Memorial Lutheran Hospital, Milwaukee
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07139977DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Madison
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT06989112FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Wisconsin, Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Wisconsin Carbone Cancer Center, Madison
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Madison
RecruitingPhase 2
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT05489211ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- Froedtert and Medical College of Wisconsin, Milwaukee
RecruitingPhase 2
Ages 18 and older · Women · Updated Aug 21, 2026 · NCT05548296Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
Recruiting
Ages 65 and older · All sexes · Updated Aug 20, 2026 · NCT07227077A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Waukesha
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 121, Milwaukee
RecruitingPhase 2
Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Wisconsin Institute Medical Research- UW Cancer Connect, Madison
RecruitingPhase 2
Ages 18 and older · Women · Updated Jun 2, 2026 · NCT06730347A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Froedtert & the Medical College of Wisconsin, Milwaukee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2025 · NCT05902988SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.